ATS Crit Care Profile picture
May 23 5 tweets 3 min read Twitter logo Read on Twitter
Next up: Dr Elizabeth Munroe, when do we add vasopressors in #sepsis ?

#ATS2023 @atscommunity

Early vasopressors will:
- control shock faster
- allow leas fluids

Look up the #CENSER and #CLOVERS trials
In #CLOVERS restrictive fluid groups show no difference in major outcomes compared to liberal group
How do we administer vasopressors?

Do we always need a CVC?

Check out the reviews 👇🏻 Image
#CLOVERS trial: 84% had vasopressors started peripherally

✅ faster
✅ less fluids

42% of patients alive at day 3 never needed a CVC

Complication rate from peripheral vasopressors was low

No difference in major outcomes Image
✅Norepinephrine appears safe at low dose peripherally
⛔️ vasopressin not well studied and most prohibitive when used peripherally

#ATS2023

More evidence needed to assess when vasopressin needs to be added.

NE remains 1st line

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with ATS Crit Care

ATS Crit Care Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ATSCritCare

May 23
C4: Making it Personal: Individualizing Resuscitation Targets - Pavan Bhatraju #ATS2023
Image
Can molecular phenotypes guide resuscitation? Image
Read 4 tweets
May 23
Dr Ivor Douglas discussing pathophysiology of IV fluids and vasopressors in #sepsis

#ATS2023

Follow below for highlights!

@atscommunity Image
Too much or too little fluids can have consequences.

What is the optimal range for fluids? Image
Excess fluid balance (> 5L in 1st day) is associated with increased mortality Image
Read 6 tweets
May 22
Here we go #ATS2023

Let’s talk about next generation trials.

First up is Mattew Semler discussing the ABCs of future trials.

@atscommunity Image
The equilibrium is being disrupted and new evolving trial designs are emerging

#ATS2023 @atscommunity Image
@MichelleNgGong discussing advantages of platform trials compared to traditional trials which be costly and ineffective

Frequent analyses, multiple interventions can be studied and ability to add additional arms are advantages of platform trials

#ATS2023 @atscommunity ImageImage
Read 6 tweets
May 21
Next: This is your brain on (ICU) Drugs - Image
First up - Tackling delirium - an educational tool to improve nursing-level identification with Dr. Balaban
Nursing level education improvement with educational modules may improve detection of delirium in ICU ImageImage
Next up - Dr. Anderson presents standardized metrics for sedation and delirium assessment -
🗣️ Educational, time interval assessment and performance feedback resulted in greater fidelity to guideline recommendations. ImageImage
Read 8 tweets
May 21
Next: ⁦@MichelleNgGong⁩ and Ivor Douglas ⁦@com543⁩ presenting the CLOVERS trial - early or liberal fluid management for sepsis induced hypotension nejm.org/doi/full/10.10…
CLOVERS visual abstract Image
Complex protocols for both Fluid Liberal and Fluid Conservative arms.

Options in each arm to allow for "Rescue" for fluids or vasopressors based on pre-specified criteria
Read 12 tweets
May 21
Up next: @erinkkross presenting on investigation of methods to improve goals of card (GOC) communication for critically ill patients
jamanetwork.com/journals/jama/…
Study first author is the late and very missed @JRandallCurtis1.

mednews.uw.edu/news/curtis/in…
Rationale: clinicians don't discuss GOC communications, but pragmatic *and* efficient strategies to increase and improve these critical interactions are lacking

jamanetwork.com/journals/jamai…
Read 19 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(